Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire L Adams

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Neuro-Oncology Advances|July 10, 2020
Constitutive activation of the EGFR-STAT1 axis increases proliferation of meningioma tumor cellsSara Ferluga, Daniele Baiz, David A Hilton, et al.
Archivum Immunologiae Et Therapiae Experimentalis|July 13, 2004
Tracking lymphocytes in vivoClaire L Adams, Natalie Kobets, Gordon R Meiklejohn, et al.
Cancers|July 8, 2020
The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient MeningiomaJade Lyons Rimmer, Emanuela Ercolano, Daniele Baiz, et al.
Acta Neuropathologica Communications|December 16, 2023
A novel patient-derived meningioma spheroid model as a tool to study and treat epithelial-to-mesenchymal transition (EMT) in meningiomasLaurien L van de Weijer, Emanuela Ercolano, Ting Zhang, et al.
International Journal of Molecular Sciences|January 12, 2021
Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I MeningiomasAgbolahan A Sofela, David A Hilton, Sylwia Ammoun, et al.
The Journal of Clinical Endocrinology and Metabolism|April 26, 2021
Ovarian Hyperandrogenism and Response to Gonadotropin-releasing Hormone Analogues in Primary Severe Insulin ResistanceIsabel Huang-Doran, Alexandra B Kinzer, Mercedes Jimenez-Linan, et al.
Ebiomedicine|June 25, 2025
Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomasMaryam Shah, Yeasmin Akther, Claire L Adams, et al.
Oncogene|September 26, 2024
Correction: Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumoursForam Dave, Kevin Herrera, Alex Lockley, et al.
Oncogene|August 23, 2024
Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumoursForam Dave, Kevin Herrera, Alex Lockley, et al.
Clinical Epigenetics|March 13, 2022
Transcriptional, epigenetic and metabolic signatures in cardiometabolic syndrome defined by extreme phenotypesDenis Seyres, Alessandra Cabassi, John J Lambourne, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Neuro-Oncology Advances|July 10, 2020
Constitutive activation of the EGFR-STAT1 axis increases proliferation of meningioma tumor cellsSara Ferluga, Daniele Baiz, David A Hilton, et al.
Archivum Immunologiae Et Therapiae Experimentalis|July 13, 2004
Tracking lymphocytes in vivoClaire L Adams, Natalie Kobets, Gordon R Meiklejohn, et al.
Cancers|July 8, 2020
The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient MeningiomaJade Lyons Rimmer, Emanuela Ercolano, Daniele Baiz, et al.
Acta Neuropathologica Communications|December 16, 2023
A novel patient-derived meningioma spheroid model as a tool to study and treat epithelial-to-mesenchymal transition (EMT) in meningiomasLaurien L van de Weijer, Emanuela Ercolano, Ting Zhang, et al.
International Journal of Molecular Sciences|January 12, 2021
Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I MeningiomasAgbolahan A Sofela, David A Hilton, Sylwia Ammoun, et al.
The Journal of Clinical Endocrinology and Metabolism|April 26, 2021
Ovarian Hyperandrogenism and Response to Gonadotropin-releasing Hormone Analogues in Primary Severe Insulin ResistanceIsabel Huang-Doran, Alexandra B Kinzer, Mercedes Jimenez-Linan, et al.
Ebiomedicine|June 25, 2025
Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomasMaryam Shah, Yeasmin Akther, Claire L Adams, et al.
Oncogene|September 26, 2024
Correction: Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumoursForam Dave, Kevin Herrera, Alex Lockley, et al.
Oncogene|August 23, 2024
Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumoursForam Dave, Kevin Herrera, Alex Lockley, et al.
Clinical Epigenetics|March 13, 2022
Transcriptional, epigenetic and metabolic signatures in cardiometabolic syndrome defined by extreme phenotypesDenis Seyres, Alessandra Cabassi, John J Lambourne, et al.
Pageof 3